Website Terms of Use

Welcome to imdxinc.com (the “Site”). Please read these terms and conditions (“Terms of Use”) carefully before using this Site. By accessing or using the Site, you agree to be bound by these terms and conditions. The provision of information and services on this Site by the owners and operators of imdxinc.com and their agents are subject to your agreement to the terms and conditions below.

  1. Scope of These Terms; Site Use 

These terms of use apply to your use of the Site. The Site is owned and operated by Insight Molecular Diagnostics Inc. (“iMDx”).

iMDx grants you a limited, revocable, nonexclusive license to use the Site solely for your own personal use and not for republication, distribution, assignment, sublicense, sale, preparation of derivative works, or other use. You agree not to copy materials on the site, reverse engineer or break into the site, or use materials, products or services in violation of any law. The use of this website is at the discretion of iMDx, and iMDx may terminate your use of this website at any time.

  1. Disclaimer of Content

This site provides information about our company and its subsidiaries, and the products and services offered by each of them, including diagnostic health testing and services, data analysis, clinical trials capabilities, and information about various health conditions.

The clinical information contained within our site is intended for the use of healthcare professionals. Healthcare professionals should exercise their own clinical judgment when using our content, tools, or databases.

If you are a patient or healthcare consumer, you should not use information found on this Site to replace a relationship with your physician or other healthcare professional and should not rely on that information as professional medical advice. Always seek the advice of your physician or other qualified healthcare provider concerning questions you have regarding a medical condition, and before starting, stopping, or modifying any treatment or medication. In the case of a health emergency, seek immediate assistance from emergency personnel. Never delay obtaining medical advice or disregard medical advice because of something you have or have not read on this Site.

The information (including, without limitation, advice, and recommendations) and services on this Site are intended solely as a general educational aid and are neither medical nor health care advice for any individual problem nor a substitute for medical or other professional advice and services from a qualified health care provider familiar with your medical history. Use of this Site does not create a physician-patient relationship or other healthcare provider and patient relationship. Nothing contained in this Site is intended to be used for medical diagnosis or treatment.

While iMDx attempts to keep all the information on the Site up-to-date, medical treatment and knowledge change quickly, and this Site should not be considered error-free or as a comprehensive source of all information on a particular topic. iMDx makes no warranties or representations as to the accuracy of the content of the Site and assumes no responsibility for any consequences relating directly or indirectly to any action or inaction you take based upon the information and material on this Site. Your use of the Site is subject to additional disclaimers and caveats that may appear throughout these terms and conditions and the iMDx Site. You assume the entire risk of loss in using this Site and materials contained in the Site.

Nothing contained in this Terms of Use or your use of the Site shall be construed to constitute either party as a partner, joint venturer, employee or agent of the other party, nor shall either party hold itself out as such. Neither party has any right or authority to incur, assume or create, in writing or otherwise, any warranty, liability or other obligation of any kind, express or implied, in the name of or on behalf of the other party, it being intended by both parties that each shall remain independent contractors responsible for its own actions.

Features, prices, and specifications of products or services described or depicted on the Site are subject to change at any time without notice.

Certain information on this site may be provided by third parties. Please review the website, product labels, disclaimers, and other information of such third parties for additional terms and conditions.

The Site is intended for adults only. This website is not intended for any children under the age of 13.

  1. Copyright, Trademarks, and other Intellectual Property

Copyright, trademark, patent, and other applicable laws protect the services and materials appearing on the Site. All materials on the Site may be accessed, downloaded, or printed for the noncommercial purpose of scientific or educational advancement or within the scope allowable by these terms and conditions. No other use of these materials may be made without express written permission of the operators of iMDx. Any unauthorized use of the words or images on this Site may violate copyright laws, trademark laws, the laws of privacy and publicity, and civil and criminal statutes.

The Site includes material that is derived in whole or in part from materials that are copyrighted, including the format and layout of the Site. The copyrights are owned by iMDx, or for licensed content, the content providers.

imdxinc.com is owned by iMDx. None of the names, trademarks, service marks and logos of iMDx (including of its products and services) appearing on this Site may be used in any advertising or publicity, or otherwise to indicate iMDx’s sponsorship of or affiliation with any product or service without express written permission of iMDx. Nothing contained on the Site should be construed as granting, by implication, estoppel, waiver or otherwise, any license or right of use to any trademark displayed on the Site without the written permission of the owners and operators of imdxinc.com or the third-party owner of the trademark, if any. This Site may contain other proprietary notices and copyright information, the terms of which must be observed and followed.

  1. Right to Change Terms and Conditions

iMDx may, at any time and from time to time, change these terms and conditions. Any changes to these terms and conditions will be effective immediately upon posting of the changed terms and conditions on the Site. You agree to review these terms and conditions periodically, and use of the Site following any such change constitutes your agreement to follow and be bound by the terms and conditions as changed.

  1. Links to Other Sites

This Site may contain third party-owned content (e.g., articles, data feeds, abstracts, etc.) and may also include hypertext links to third party-owned web sites. We provide such third-party content and links as a courtesy to our users. We have no control over any third party-owned web sites or content referenced, accessed by or available on this Site and, therefore, we do not endorse, sponsor, recommend or otherwise accept any responsibility for such third-party web sites or content or for the availability of such web sites. IN PARTICULAR, WE DO NOT ACCEPT ANY LIABILITY ARISING OUT OF ANY ALLEGATION THAT ANY THIRD PARTY-OWNED CONTENT (WHETHER PUBLISHED ON THIS, OR ANY OTHER, WEB SITE) INFRINGES THE INTELLECTUAL PROPERTY RIGHTS OF ANY PERSON OR ANY LIABILITY ARISING OUT OF ANY INFORMATION OR OPINION CONTAINED ON SUCH THIRD-PARTY WEB SITE OR CONTENT. If you link to third party sites from iMDx, we encourage you to consult the policy statements of each site you visit. 

  1. Links to This Site

We welcome links to this web site. We do not wish and do not give permission to be linked to or from any third-party web site or link which contains:

  • any information that misrepresents the nature of your relationship with our organization, or incorrect facts or data about our organization; or
  • any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any content constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, provincial, national or international law, regulation which may be damaging or detrimental to the activities, operations, credibility or integrity of iMDx or its subsidiaries; or
  • any material or information of any kind, which promotes racism, bigotry, hatred, or physical harm of any kind against any group or individual, could be harmful to minors, harasses or advocates harassment of another person, provides material that exploits people under the age of 18 in a sexual or violent manner, provides instructional information about illegal activities, including, without limitation, the making or buying of illegal weapons; or
  • any information, software or other material which violates or infringes upon the rights of others, including material which is an invasion of privacy or publicity rights, or which is protected by copyright, trademark, or other proprietary rights.

We reserve the right to prohibit or refuse to accept any link to the web site, including, without limitation, any link which contains or makes available any content or information of the foregoing nature, at any time.

  1. Logins

Certain features or services offered on or through the Site may require you to open an account (including setting up a login and password). You are entirely responsible for maintaining the confidentiality of the information you hold for your account, including your password, and for any and all activity that occurs under your account as a result of your failing to keep this information secure and confidential. You agree to notify iMDx immediately of any unauthorized use of your account or password, or any other breach of security. You may be held liable for losses incurred by iMDx or any other user of or visitor to the Site due to someone else using your login, password, or account as a result of your failing to keep your account information secure and confidential.

You may not use anyone else’s login, password, or account at any time without the express permission and consent of the holder of that login, password, or account. iMDx cannot and will not be liable for any loss or damage arising from your failure to comply with these obligations.

  1. Purchases

Additional terms and conditions may apply to purchases of goods or services and to specific portions or features of the Site, including contests, promotions, or other similar features, all of which terms are made a part of these Terms of Use by this reference. You agree to abide by such other terms and conditions, including where applicable representing that you are of sufficient legal age to use or participate in such service or feature. If there is a conflict between these Terms of Use and the terms posted for or applicable to a specific portion of the Site or for any service offered on or through the Site, the latter terms shall control with respect to your use of that portion of the Site or the specific service.

  1. Advertising and Sponsorships

We do not accept paid advertisements or sponsorships on this Site.

  1. Disclaimer of Warranty; Limitation of Liability

iMDx, ITS AFFILIATES, AND SUPPLIERS DISCLAIM ALL EXPRESS AND IMPLIED WARRANTIES WITH REGARD TO THE INFORMATION, SERVICES AND MATERIALS CONTAINED ON THIS SITE, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT. YOUR USE OF THIS SITE IS AT YOUR OWN RISK. ACCESS TO THIS SITE MAY BE INTERRUPTED AND INFORMATION, SERVICES AND MATERIALS MAY NOT BE ERROR-FREE. NONE OF iMDx, ITS SUPPLIERS OR ANYONE ELSE INVOLVED IN CREATING, PRODUCING OR DELIVERING THIS SITE OR THE INFORMATION, SERVICES AND MATERIALS CONTAINED HEREIN ASSUMES ANY LIABILITY OR RESPONSIBILITY FOR THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY INFORMATION, SERVICES AND MATERIALS PROVIDED ON THIS SITE; THEY ALSO SHALL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES ARISING OUT OF YOUR USE OF, OR INABILITY TO USE, THIS SITE. ALL INFORMATION, SERVICES AND MATERIALS ARE PROVIDED “AS IS” AND “AS AVAILABLE” WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED.

UNDER NO CIRCUMSTANCES WILL iMDx, ITS AFFILIATES, OR SUPPLIERS BE LIABLE OR RESPONSIBLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL (INCLUDING DAMAGES FROM LOSS OF BUSINESS, LOST PROFITS, LITIGATION, OR THE LIKE), SPECIAL, EXEMPLARY, PUNITIVE, OR OTHER DAMAGES, UNDER ANY LEGAL THEORY, ARISING OUT OF OR IN ANY WAY RELATING TO THE SITE, YOUR SITE USE, OR THE CONTENT, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. YOUR SOLE REMEDY FOR DISSATISFACTION WITH THE SITE AND/OR CONTENT IS TO CEASE ALL OF YOUR SITE USE.

YOU ACKNOWLEDGE AND AGREE THAT THE LIMITATIONS SET FORTH ABOVE ARE FUNDAMENTAL ELEMENTS OF THIS TERMS OF USE AND THIS SITE WOULD NOT BE PROVIDED TO YOU ABSENT SUCH LIMITATIONS.

PLEASE NOTE THAT SOME JURISDICTIONS MAY NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO SOME OF THE ABOVE EXCLUSIONS MAY NOT APPLY TO YOU. CHECK YOUR LOCAL LAWS FOR ANY RESTRICTIONS OR LIMITATIONS REGARDING THE EXCLUSION OF IMPLIED WARRANTIES.

  1. Privacy Policy

If you had testing or other healthcare services performed by us, in which we received or generated PHI (as such term is defined under the Health Information Portability and Accountability Act, as amended), please see our Notice of Privacy Practices found here. Visitors of the Site should review our Privacy Policy found here. iMDx reserves the right, and you authorize us, to use and assign all information regarding site uses by you and all information provided by you in any manner consistent with our Privacy Policy.

  1. Indemnification

You agree to indemnify, defend and hold harmless iMDx, its suppliers and iMDx’s respective affiliates, employees, officers, directors, agents, servants and representatives of each from any liability, loss, claim, suit, damage, and expense (including reasonable attorneys´ fees and expenses) related to (i) your violation of these terms and conditions and (ii) your posting of material to this Site, if any.

  1. Applicable Law

These terms and conditions and the resolution of any dispute related to these terms and conditions shall be construed in accordance with the laws of the State of California. Any dispute between iMDx and you related to these terms and conditions shall be resolved exclusively by the state and federal courts of the State of California.

This Web site can be accessed from the United Stated and other countries worldwide. Since the laws of each State or country may differ, you agree that the statutes and laws of the State of California, without regard to any principles of conflicts of law, will apply to all matters relating to the use of this site.

iMDx makes no representation that material on this site is appropriate or available for use in other locations and accessing them from territories where their content is illegal is prohibited. Those who choose to access the site from other locations do so on their own initiative and are responsible for compliance with local laws.

  1. Termination

These terms and conditions are effective unless and until modified as noted above, or terminated, at any time, by iMDx. If, in the sole discretion of iMDx, you fail to comply with these terms and conditions, iMDx may terminate these terms and conditions without notice and deny you access to the Site.

  1. Contact Information

Executive Office
iMDx
2 International Plaza Dr. Suite 510
Nashville, TN 37217
615.255.8880

Specific questions and comments should be directed to the appropriate department via our Contact Us page. While we make every effort to respond to all emails within one (1) business week, we cannot guarantee a response to every electronic communication.

James Liu

James Liu joined iMDx in July 2021 and was appointed Vice President of Accounting, Controller, Treasurer, and Principal Accounting Officer in March 2025.  He has held several key roles at iMDx, including Senior Director, Controller & Principal Accounting Officer and Manager of SEC Reporting & Compliance.  James also served as interim Principal Financial Officer from August 2023 to June 2024, overseeing financial operations and public company reporting.

Before iMDx, James served as Accounting Manager at Acacia Research Corporation, where he led the SEC reporting and compliance, accounting close, and all other financial reporting requirements of an opportunistic capital platform that identifies and acquires other. He also worked as Senior Accountant at Gatekeeper Systems, Inc. and as Senior Assurance Associate at BDO USA, LLP, gaining deep expertise in financial reporting and assurance practices across multiple industries.

James holds a BASc degree from the University of California, San Diego, and is a Certified Public Accountant.

Peter Hong

Peter Hong oversees iMDx’s legal department. Before joining iMDx in August 2021, Peter was an associate at Stradling Yocca Carlson & Rauth, P.C., where he represented both public and private companies in capital markets, M&A, and corporate governance matters. Prior to that, he worked at the New York office of Covington & Burling LLP, where he represented underwriters in the initial public offerings and follow-on offerings of biotechnology companies.  At Covington, Peter also advised overseas clients with regard to restructuring, employment matters and the formation of U.S. subsidiaries.

Peter earned his JD from Columbia Law School and his Bachelor of Science in Business Administration from Washington University in St. Louis. He is admitted to practice law in New York and California.

Ryan Andrews

Ryan Andrews joined iMDx in 2019 and currently serves as Vice President of Commercial, leading the strategic commercialization of iMDx’s innovative products and solutions. Prior to this role, he held key leadership positions within the company, including Director and Senior Director of Marketing, where he played a pivotal role in shaping iMDx’s market strategy and brand presence.

With extensive experience in the diagnostics and life sciences industry, Ryan brings a deep understanding of market dynamics, business development, and commercial execution. His expertise spans product commercialization, strategic partnerships, and market expansion, ensuring iMDx’s solutions reach the healthcare providers and patients who need them most.

Before joining iMDx, Ryan was a Principal at Bethesda Group, LLC, a boutique consulting firm specializing in guiding small and mid-stage diagnostic companies and investment groups through market entry, product launches, and commercialization strategies. He has also held sales, marketing, and operational leadership roles at Thermo Fisher Scientific, Life Technologies, and Cytovance Biologics, where he gained extensive experience in the biotechnology, diagnostics, and life sciences sectors.

Ryan holds an MBA from the University of Mississippi and remains committed to advancing precision diagnostics and improving patient outcomes through innovative commercial strategies.

Sandra O’Donald

Sandra is an activator and results-driven leader with expertise in operational leadership, commercialization, and corporate integration. With a strong record of driving transformation across small and mid-sized organizations, Sandra brings a unique ability to align cross-functional teams, streamline operations, and deliver measurable business outcomes.

Sandra joined iMDx in December 2019, and in her current role, she leads business operations in support of product development, working closely with senior leadership to ensure alignment with the company’s long-term strategic goals. She champions scalable processes, fosters continuous improvement, and supports innovation throughout the organization.

Beyond her corporate responsibilities, Sandra serves as Vice President of the Orange County chapter of the Healthcare Businesswomen’s Association (HBA), where she partners with the board to shape the chapter’s vision, drive strategic initiatives, and engage with the Chapter Advisory Board to elevate leadership and inclusion in the healthcare industry.

Sandra is known for driving consensus among teams, focused execution of goals and turning strategy into action.

Sandra earned a Bachelor of Business Administration (B.B.A.) and HR Management Certification from California State University, Fullerton.

Andrea James

Andrea James is an expert in guiding financial strategy through multiple phases of growth, raising and stewarding capital, and building relationships with high quality institutional investors.  Prior to joining iMDx in 2024, she served in a series of escalating roles at Axon Enterprise, Inc. (Nasdaq: AXON), including Chief Communications Officer and Head of Investor Relations, and Senior Vice President of Strategy. She played a key role in the company’s growth from a $1 billion to a $20 billion market capitalization and established Axon’s corporate strategy function, overseeing capital stewardship, mergers and acquisitions, strategic partnerships, and investments. Her leadership contributed to more than $550 million in equity capital offerings.

 Before joining Axon, Andrea assisted Tesla, Inc. (Nasdaq: TSLA) with strategic investor relations, and has also served as Vice President and Senior Research Analyst at Dougherty & Co. (now Colliers Securities), specializing in researching disruptive technologies.

Andrea holds a Bachelor of Science, summa cum laude, in Computer Information Systems from American University. She also earned a Master of Science in Journalism from Northwestern University, graduating with Kappa Tau Alpha honors.

Yuh-Min (Johnson) Chiang, PhD

Johnson Chiang is an experienced technology leader with a strong background in molecular diagnostics, focusing on product development, systems integration, and regulatory strategy. Johnson joined iMDx in 2021, having previously served as Chief Technology Officer at Alveo Technologies, an IVD company that specializes in developing cutting-edge molecular diagnostic tests. At iMDx, he continues to leverage his expertise to drive innovation in diagnostic solutions.

Previously, Johnson led the development of the be.well COVID-19 Test at Alveo Technologies, which completed a U.S. clinical trial and earned the CE mark and UK approval. In addition to his leadership in product development, he was involved in fundraising efforts that raised $50MM over four years and played a key role in securing the XPrize Grand Award for Rapid COVID Testing. Earlier in his career, Johnson was the Head of Systems Integration & Molecular Biology at Foundation Medicine, Inc., and held senior management roles at Life Technologies and Thermo Fisher Scientific. One of his key achievements was leading the Oncomine Dx Target Test, the first NGS-based CDx test approved by the FDA. Additionally, he holds several patents and has published numerous papers in biotechnology.

Johnson holds a Ph.D. in BioMEMS (Micro Electro-Mechanical Systems) from the University of California, Irvine. He also earned a Master of Engineering from The Ohio State University.

Prof. Dr. Ekkehard Schütz, MD, PhD, FAACC

Ekkehard (Ekke) Schütz is a renowned leading expert in molecular genetics, diagnostics, and cell-free DNA (cf-DNA) research. He joined iMDx in April 2021 through its acquisition of Chronix Biomedical Inc. and now serves as Managing Director of Chronix Biomedical GmbH (a fully owned subsidiary of iMDx) and Chief Medical Officer (CMO) for Europe.

Under his leadership, Chronix became a leader in cf-DNA diagnostics, producing numerous publications and securing a broad patent portfolio, including ten patent families with many issued patents in the U.S. and Europe, which he invented.

Fellow of the National Academy for Clinical Biochemistry (now FAACC) since 2014, Ekke has published over 190 peer-reviewed papers, contributed to 100+ congress abstracts, and received several international scientific awards. He has also been a reviewer for top scientific journals, including PNAS, Clinical Chemistry, Clinical Biochemistry, and Nucleic Acids Research.

Ekke trained in laboratory medicine at Georg-August-University Hospital in Goettingen, Germany under Prof. Dr. Michael Oellerich, a renowned expert in therapeutic drug monitoring and transplantation surveillance.

Josh Riggs

Josh Riggs is an accomplished and results-driven business leader with extensive experience in market access, molecular diagnostics, and strategic business development. He joined iMDx in August 2020, where he quickly became a key driver of the company’s growth and innovation. Initially serving as Senior Director of Business Development and General Manager of Transplant, Josh demonstrated exceptional leadership and business acumen, which ultimately led to his appointment as CEO in December 2022. As CEO, Josh has spearheaded the strategic pivot of iMDx, leading the organization to decentralize its testing approach and expand its impact on patient care.

Prior to his tenure at iMDx, Josh founded and led Intelliger Consulting, a firm specializing in healthcare marketing strategies. He also served as a principal at Bethesda Group, LLC, where he advised diagnostic companies and investors on market entry, commercialization, and expansion strategies.

Before venturing into the healthcare and diagnostics sectors, Josh gained valuable operational experience in the manufacturing industry. As part of the team at Industrial Timber, a startup manufacturer, he was responsible for managing and establishing multiple manufacturing facilities across the southeastern United States.

Josh holds an MBA from the University of Mississippi.

Order Request

iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.

Order Request

iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.

Order Request

iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.

Order Request

iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.

Information Request

iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.

Thanks for your interest in

Information Request

iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.